New Zealand's fledgling ag biotech sector to get boost from NZ$100 million investment fund planned by Celentis

Commercial science company, Celentis, is expanding its role in commercialising New Zealand biotechnology

October 03

Grasslanz Technology Ltd. , new primary vehicle for commercialising AgResearch plant technologies, will develop proprietary forage cultivars, grass endophytes and applied biotechnology

September 03

New Zealand joint venture EnCoate sets its sights on organic pesticides

August 03

Celentis boosted by $5 million pre-seed fund